Skip to main content
Psychedelic medicine biotech firm MindMed is conducting a clinical trial in Switzerland that will evaluate the use of MDMA and LSD in combination to determine whether the former can increase positive subject drug effects and reduce negative emotions and anxiety that are sometimes associated with the latter.
Toronto-based Awakn Life Sciences and contract research organization PRA Health Sciences have announced plans to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder.
UFC, the top mixed martial arts promotion in the United States, has approached researchers at Johns Hopkins University to explore the potential use of psychedelics in treatment for its fighters, according to media reports.
Following the announcement of new executives and plans for a translational research program on the use of psychedelics in the treatment of physical and psychological pain, Mind Cure is acquiring an ownership interest in psychedelic-assisted therapy provider ATMA Journey Centers.
Repeated intravenous (IV) ketamine infusions may significantly reduce the severity of symptoms in individuals with chronic post-traumatic stress disorder (PTSD).
Back to Top